Sep 16, 2020 / 02:15PM GMT
David Reed Risinger - Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst
Great. So good morning, everyone. This is Dave Risinger from Morgan Stanley. I cover both major and specialty pharmaceuticals, and it's my pleasure to host Phibro for our discussion. I do need to start with a disclaimer, and that is, please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. It's not for members of the press. If you're a member of the press, please disconnect and reach out separately. For important disclosures, please see the website, www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.
So I'm pleased to have Donny Bendheim, who is a company Director and Executive Vice President of Corporate Strategy, he's held a variety of operational and leadership roles at the company since 1997. And also Dick Johnson, who is the CFO, and he's been with
Phibro Animal Health Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers